Lymphoma Hub (@lymphomahub) 's Twitter Profile
Lymphoma Hub

@lymphomahub

A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia. linktr.ee/LymphomaHub_ #lymsm

ID: 1582593798

linkhttp://www.lymphomahub.com calendar_today10-07-2013 08:56:22

10,10K Tweet

10,10K Followers

2,2K Following

Lymphoma Hub (@lymphomahub) 's Twitter Profile Photo
Lymphoma Hub
@lymphomahub

2 months ago

CONGRESS | #EHA2025 | PRESENTATION Yuqin Song, Peking University Cancer Hospital, shares results from a phase I trial of SHR2554, an oral, small molecule EZH2 inhibitor, in patients with R/R PTCL (N = 67). The primary endpoint was met, with an ORR of 64.2%. A phase III trial

CONGRESS | #EHA2025 | PRESENTATION Yuqin Song, Peking University Cancer Hospital, shares results from a phase I trial of SHR2554, an oral, small molecule EZH2 inhibitor, in patients with R/R PTCL (N = 67). The primary endpoint was met, with an ORR of 64.2%. A phase III trial